HOLOGIC INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 48 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-12-10: Reporting owner Thornal Kevin R; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2020-12-10: Reporting owner Thornal Kevin R; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2020-11-18: Reporting owner Griffin John M.; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2020-11-17: Reporting owner COHN BENJAMIN JORDAN; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-12-10 | Thornal Kevin R Officer (Div. President, Diagnostics) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,633 0 owned after | $39.96 exercise price | 2020-12-14 | |
| 2020-12-10 | Thornal Kevin R Officer (Div. President, Diagnostics) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,236 0 owned after | $37.64 exercise price | 2020-12-14 | |
| 2020-11-18 | Griffin John M. Officer (General Counsel) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −22,900 0 owned after | $39.96 exercise price | 2020-11-20 | |
| 2020-11-17 | COHN BENJAMIN JORDAN Officer (Principal Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $26.21 exercise price | 2020-11-19 | |
| 2020-11-12 | COHN BENJAMIN JORDAN Officer (Principal Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,542 5,000 owned after | $26.21 exercise price | 2020-11-16 | |
| 2020-11-09 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +123,801 123,801 owned after | $68.35 exercise price | 2020-11-12 | |
| 2020-11-09 | Oberton Karleen Marie Officer (Chief Financial Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,767 23,767 owned after | $68.35 exercise price | 2020-11-12 | |
| 2020-11-09 | Verstreken Jan Officer (Group President, International) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,509 12,509 owned after | $68.35 exercise price | 2020-11-12 | |
| 2020-11-09 | Thornal Kevin R Officer (Div. President, Diagnostics) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,512 17,512 owned after | $68.35 exercise price | 2020-11-12 | |
| 2020-11-09 | Griffin John M. Officer (General Counsel) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,265 21,265 owned after | $68.35 exercise price | 2020-11-12 | |
| 2020-11-09 | Daugherty Sean S. Officer (Group President, BSH & Surg.) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,010 15,010 owned after | $68.35 exercise price | 2020-11-12 | |
| 2020-11-09 | COHN BENJAMIN JORDAN Officer (Principal Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,505 7,505 owned after | $68.35 exercise price | 2020-11-12 | |
| 2020-11-09 | Bebo Allison P Officer (SVP, Human Resources) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,258 11,258 owned after | $68.35 exercise price | 2020-11-12 | |
| 2020-11-09 | GARRETT SCOTT T Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,146 0 owned after | $22.35 exercise price | 2020-11-12 | |
| 2020-11-04 | Stamoulis Christiana Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,146 0 owned after | $22.35 exercise price | 2020-11-06 | |
| 2020-11-02 holding as of filing | Verstreken Jan Officer (Group President, International) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $45.61 exercise price | 2020-11-02 | ||
| 2020-11-02 holding as of filing | Verstreken Jan Officer (Group President, International) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $40.97 exercise price | 2020-11-02 | ||
| 2020-11-02 holding as of filing | Verstreken Jan Officer (Group President, International) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $40.85 exercise price | 2020-11-02 | ||
| 2020-11-02 holding as of filing | Verstreken Jan Officer (Group President, International) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $40.85 exercise price | 2020-11-02 | ||
| 2020-11-02 holding as of filing | Verstreken Jan Officer (Group President, International) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $56.97 exercise price | 2020-11-02 | ||
| 2020-09-22 | Oberton Karleen Marie Officer (Chief Financial Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,461 0 owned after | $26.21 exercise price | 2020-09-23 | |
| 2020-09-21 | Oberton Karleen Marie Officer (Chief Financial Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 5,461 owned after | $26.21 exercise price | 2020-09-23 | |
| 2020-09-10 holding as of filing | Daugherty Sean S. Officer (Group President, BSH & Surg.) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $45.61 exercise price | 2020-09-10 | ||
| 2020-09-10 holding as of filing | Daugherty Sean S. Officer (Group President, BSH & Surg.) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $40.97 exercise price | 2020-09-10 | ||
| 2020-09-10 holding as of filing | Daugherty Sean S. Officer (Group President, BSH & Surg.) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $40.85 exercise price | 2020-09-10 | ||
| 2020-09-10 holding as of filing | Daugherty Sean S. Officer (Group President, BSH & Surg.) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $44.35 exercise price | 2020-09-10 | ||
| 2020-08-03 | COHN BENJAMIN JORDAN Officer (Principal Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,986 0 owned after | $23.82 exercise price | 2020-08-05 | |
| 2020-06-30 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,493 0 owned after | $26.21 exercise price | 2020-07-02 | |
| 2020-05-22 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,493 10,493 owned after | $26.21 exercise price | 2020-05-27 | |
| 2020-05-15 | Thornal Kevin R Officer (Div. President, Diagnostics) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,888 0 owned after | $26.01 exercise price | 2020-05-19 | |
| 2020-05-13 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −215,996 0 owned after | $22.29 exercise price | 2020-05-15 | |
| 2020-05-01 | GARRETT SCOTT T Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,204 0 owned after | $20.34 exercise price | 2020-05-05 | |
| 2020-04-28 | Griffin John M. Officer (General Counsel) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,773 0 owned after | $32.38 exercise price | 2020-04-30 | |
| 2020-04-28 | Griffin John M. Officer (General Counsel) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,133 0 owned after | $32.38 exercise price | 2020-04-30 | |
| 2020-03-09 | CRAWFORD SALLY Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,146 0 owned after | $22.35 exercise price | 2020-03-11 | |
| 2020-03-05 | Wendell Amy McBride Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,322 7,322 owned after | $47.36 exercise price | 2020-03-09 | |
| 2020-03-05 | Stamoulis Christiana Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,322 7,322 owned after | $47.36 exercise price | 2020-03-09 | |
| 2020-03-05 | Nawana Namal Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,322 7,322 owned after | $47.36 exercise price | 2020-03-09 | |
| 2020-03-05 | HANTSON LUDWIG Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,322 7,322 owned after | $47.36 exercise price | 2020-03-09 | |
| 2020-03-05 | GARRETT SCOTT T Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,322 7,322 owned after | $47.36 exercise price | 2020-03-09 | |
| 2020-03-05 | Dockendorff Charles J Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,322 7,322 owned after | $47.36 exercise price | 2020-03-09 | |
| 2020-03-05 | CRAWFORD SALLY Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,322 7,322 owned after | $47.36 exercise price | 2020-03-09 | |
| 2020-02-03 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −215,996 215,996 owned after | $22.29 exercise price | 2020-02-05 | |
| 2020-01-13 | Griffin John M. Officer (General Counsel) | 4/A | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,532 2,133 owned after | $32.38 exercise price | 2020-01-17 | |
| 2020-01-13 | Griffin John M. Officer (General Counsel) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,532 2,133 owned after | $32.38 exercise price | 2020-01-15 | |
| 2020-01-13 | Griffin John M. Officer (General Counsel) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,092 2,773 owned after | $32.38 exercise price | 2020-01-15 | |
| 2020-01-02 | Oberton Karleen Marie Officer (Chief Financial Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,375 0 owned after | $21.45 exercise price | 2020-01-06 | |
| 2020-01-02 | Oberton Karleen Marie Officer (Chief Financial Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,973 0 owned after | $23.82 exercise price | 2020-01-06 |